Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?

Data on therapeutic drug monitoring of novel, broad-spectrum, and promising antifungal agent Isavuconazole sheds light on factors associated with subtherapeutic drug levels, however, a few other parameters, which characterize the critically ill patients, if included in the analysis, would have impro...

Descripción completa

Detalles Bibliográficos
Autor principal: Salhotra, Ripenmeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291658/
https://www.ncbi.nlm.nih.gov/pubmed/37378375
http://dx.doi.org/10.5005/jp-journals-10071-24450
_version_ 1785062731954520064
author Salhotra, Ripenmeet
author_facet Salhotra, Ripenmeet
author_sort Salhotra, Ripenmeet
collection PubMed
description Data on therapeutic drug monitoring of novel, broad-spectrum, and promising antifungal agent Isavuconazole sheds light on factors associated with subtherapeutic drug levels, however, a few other parameters, which characterize the critically ill patients, if included in the analysis, would have improved the understanding of drugs pharmacokinetics in this subset. HOW TO CITE THIS ARTICLE: Salhotra R. Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill? Indian J Crit Care Med 2023;27(6):454–455.
format Online
Article
Text
id pubmed-10291658
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-102916582023-06-27 Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill? Salhotra, Ripenmeet Indian J Crit Care Med Letter to the Editor Data on therapeutic drug monitoring of novel, broad-spectrum, and promising antifungal agent Isavuconazole sheds light on factors associated with subtherapeutic drug levels, however, a few other parameters, which characterize the critically ill patients, if included in the analysis, would have improved the understanding of drugs pharmacokinetics in this subset. HOW TO CITE THIS ARTICLE: Salhotra R. Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill? Indian J Crit Care Med 2023;27(6):454–455. Jaypee Brothers Medical Publishers 2023-06 /pmc/articles/PMC10291658/ /pubmed/37378375 http://dx.doi.org/10.5005/jp-journals-10071-24450 Text en Copyright © 2023; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2023 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Salhotra, Ripenmeet
Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
title Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
title_full Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
title_fullStr Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
title_full_unstemmed Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
title_short Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
title_sort therapeutic drug monitoring of isavuconazole—but what about the critically ill?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291658/
https://www.ncbi.nlm.nih.gov/pubmed/37378375
http://dx.doi.org/10.5005/jp-journals-10071-24450
work_keys_str_mv AT salhotraripenmeet therapeuticdrugmonitoringofisavuconazolebutwhataboutthecriticallyill

Ejemplares similares